Sánchez-Iglesias, Santiago <br/><br/>
Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed With Bipolar Disorder.  [electronic resource] 

 -  Medicine  Feb 2016 
 - e2473 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1536-5964 
<br/><br/><label>Standard No.: </label>10.1097/MD.0000000000002473  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antidepressive Agents, Second-Generation--adverse effects<br/>Bipolar Disorder--drug therapy<br/>Cytochrome P-450 CYP2D6--genetics<br/>Genetic Markers<br/>Genotype<br/>Humans<br/>Patient Safety<br/>Quality Improvement<br/>Selective Serotonin Reuptake Inhibitors--adverse effects<br/>Treatment Outcome